Related Experiment Video
Updated: Jan 24, 2026

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Published on: April 14, 2017
OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down
Ranjie Xu1, Andrew T Brawner2, Shenglan Li3
1Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA; Department of Developmental Neuroscience, Munroe-Meyer Institute and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Abstract:
Down syndrome (DS) is a common neurodevelopmental disorder, and cognitive defects in DS patients may arise from imbalances in excitatory and inhibitory neurotransmission. Understanding the mechanisms underlying such imbalances may provide opportunities for therapeutic intervention. Here, we show that human induced pluripotent stem cells (hiPSCs) derived from DS patients overproduce OLIG2+ ventral forebrain neural progenitors. As a result, DS hiPSC-derived cerebral organoids excessively produce specific subclasses of GABAergic interneurons and cause impaired recognition memory in neuronal chimeric mice. Increased OLIG2 expression in DS cells directly upregulates interneuron lineage-determining transcription factors. shRNA-mediated knockdown of OLIG2 largely reverses abnormal gene expression in early-stage DS neural progenitors, reduces interneuron production in DS organoids and chimeric mouse brains, and improves behavioral deficits in DS chimeric mice. Thus, altered OLIG2 expression may underlie neurodevelopmental abnormalities and cognitive defects in DS patients.
Insights
Down syndrome (DS) involves neurodevelopmental issues. Researchers found that overproducing OLIG2 in Down syndrome cells leads to more inhibitory neurons, causing memory deficits, but reducing OLIG2 improved these cognitive defects.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Down syndrome (DS) is a genetic disorder associated with cognitive impairments.
- Imbalances in neurotransmission are implicated in DS-related neurodevelopmental defects.
- Human induced pluripotent stem cells (hiPSCs) offer a model to study DS pathogenesis.
Purpose of the Study:
- To investigate the role of OLIG2 in neurodevelopmental abnormalities in Down syndrome.
- To identify molecular mechanisms linking DS to altered neurotransmission and cognitive deficits.
- To explore OLIG2 as a potential therapeutic target for DS.
Main Methods:
- Generation and analysis of hiPSCs from DS patients.
- Differentiation of hiPSCs into neural progenitors and cerebral organoids.
- Assessment of gene expression, interneuron production, and behavioral deficits in neuronal chimeric mice.
- shRNA-mediated knockdown of OLIG2.
Main Results:
- DS hiPSCs overproduce OLIG2+ ventral forebrain neural progenitors.
- DS organoids exhibit excessive GABAergic interneuron production.
- Increased OLIG2 directly upregulates interneuron transcription factors.
- OLIG2 knockdown in DS models reverses gene expression, reduces interneuron overproduction, and improves recognition memory in chimeric mice.
Conclusions:
- Altered OLIG2 expression is a key factor in DS-related neurodevelopmental abnormalities.
- Overproduction of OLIG2 contributes to excessive interneuron generation and cognitive deficits in DS.
- Targeting OLIG2 presents a potential therapeutic strategy for improving cognitive function in Down syndrome.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:

